Q3 2020 Holdings
Filed 2020-11-16 | 55 holdings | $86.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $24.6M | 1,731,600 | 28.3% |
| Acutus Medical Inc(AFIB) | COM | 005111109 | $22.4M | 749,990 | 25.8% |
| Codexis Inc(CDXS) | COM | 192005106 | $16.4M | 1,400,000 | 18.9% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $14.7M | 992,000 | 17.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.5M | 208,800 | 5.2% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $3.8M | 240,000 | 4.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $45.5K | 5,984,200 | 0.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $43.1K | 2,558,472 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $28.8K | 3,640,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $19.5K | 356,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $16.6K | 1,386,300 | 0.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $16.5K | 2,959,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $15.9K | 315,550 | 0.0% |
| Vaxcyte(PCVX) | COM | 92243G108 | $15.5K | 313,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $13.3K | 527,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $11.4K | 222,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $10.8K | 3,021,436 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $10.8K | 1,799,000 | 0.0% |
| Avenue Therapeutics Inc | COM NEW | 05360L205 | $10.7K | 984,692 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $10.4K | 390,000 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $10.4K | 2,013,438 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $10.3K | 3,830,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $9.6K | 682,500 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $9.6K | 3,841,500 | 0.0% |
| Seres Therapeutics(MCRB1EUR) | COM | 81750R102 | $9.5K | 335,312 | 0.0% |
| Axovant Sciences LTD | COM | G0750W203 | $9.4K | 2,039,100 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $8.8K | 338,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $8.6K | 455,000 | 0.0% |
| Cerecor Inc | COM | 15671L109 | $7.7K | 3,372,500 | 0.0% |
| Biohaven Pharmaceutical Hldg(BHVN) | COM | G11196105 | $7.4K | 114,350 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $6.1K | 1,487,800 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $6.0K | 147,000 | 0.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $6.0K | 362,074 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.9K | 470,203 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $4.9K | 1,556,000 | 0.0% |
| Edap TMS SA(EDA) | SPONSORED ADR | 268311107 | $4.8K | 1,040,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.6K | 452,000 | 0.0% |
| Lumos Pharma Inc | COM | 55028X109 | $3.3K | 240,892 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $3.3K | 678,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $3.2K | 2,200,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $2.8K | 970,664 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.7K | 375,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $2.4K | 767,400 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $2.3K | 45,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $1.9K | 271,350 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.5K | 146,000 | 0.0% |
| Contrafect Inc(CFRXUSD) | COM NEW | 212326300 | $1.2K | 226,127 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $982 | 100,000 | 0.0% |
| Amarin Corp PLC | SPONSORED ADR NEW | 023111206 | $947 | 225,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $508 | 75,000 | 0.0% |